Baxter International Inc. Share Price Deutsche Boerse AG

Equities

BTL

US0718131099

Medical Equipment, Supplies & Distribution

Real-time Estimate Tradegate 09:12:34 10/06/2024 pm IST 5-day change 1st Jan Change
30.6 EUR +0.72% Intraday chart for Baxter International Inc. -2.26% -11.94%

Financials

Sales 2024 * 15.11B 14.07B 1,262B Sales 2025 * 15.66B 14.58B 1,308B Capitalization 16.9B 15.73B 1,411B
Net income 2024 * 703M 654M 58.69B Net income 2025 * 950M 884M 79.31B EV / Sales 2024 * 1.77 x
Net Debt 2024 * 9.85B 9.17B 822B Net Debt 2025 * 9.06B 8.43B 756B EV / Sales 2025 * 1.66 x
P/E ratio 2024 *
18 x
P/E ratio 2025 *
14.8 x
Employees 60,000
Yield 2024 *
3.6%
Yield 2025 *
3.74%
Free-Float 74.27%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.72%
1 week-2.26%
Current month+0.79%
1 month-7.00%
3 months-22.50%
6 months-7.98%
Current year-11.94%
More quotes
1 week
30.38
Extreme 30.38
30.99
1 month
30.20
Extreme 30.2
33.00
Current year
30.20
Extreme 30.2
41.01
1 year
29.45
Extreme 29.45
44.20
3 years
29.45
Extreme 29.45
77.84
5 years
29.45
Extreme 29.45
86.74
10 years
28.58
Extreme 28.583
86.74
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 01/15/01
Director of Finance/CFO 54 18/23/18
Chief Tech/Sci/R&D Officer - 01/17/01
Members of the board TitleAgeSince
Director/Board Member 73 06/17/06
Director/Board Member 64 10/22/10
Director/Board Member 64 18/19/18
More insiders
Date Price Change Volume
10/24/10 30.69 +1.02% 0
07/24/07 30.38 -1.62% 0
06/24/06 30.88 +1.25% 185
05/24/05 30.5 -1.01% 285
04/24/04 30.81 -1.88% 0

Delayed Quote Deutsche Boerse AG, June 10, 2024 at 06:59 pm IST

More quotes
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.); - kidney dialysis drugs and equipment (30.1%); - systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.; - other (20.1%). Export accounts for 52.7% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
33.16 USD
Average target price
45.44 USD
Spread / Average Target
+37.03%
Consensus